OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - CVS HEALTH Share Price

Certificat

DE000SQ7AE75

Delayed Deutsche Boerse AG 01:26:23 20/05/2024 pm IST
4.03 EUR -0.74% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - CVS HEALTH
Current month+29.30%
1 month+29.30%
Date Price Change
20/24/20 4.03 -0.74%
17/24/17 4.06 0.00%
16/24/16 4.06 -2.64%
15/24/15 4.17 -1.42%
14/24/14 4.23 +1.44%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 01:26 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ7AE7
ISINDE000SQ7AE75
Date issued 21/12/2022
Strike 101.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.93
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.45
Lowest since issue 0.88
Spread 0.02
Spread %0.49%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.68 USD
Average target price
71.37 USD
Spread / Average Target
+23.74%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW